Therefore, we chose three proteins such as BMP2, TGF-Beta, and MMP9 to confirm the expression levels using target proteomic analysis and Western blotting techniques using another newly recruited set of high-grade sarcoma patients (n = 18) of untreated and treated (n = 18) for confirmation analysis. Here, TGFB1 is linked to sarcoma.